XLO · Xilio Therapeutics, Inc.
$9.23
+0.00 (+0.00%)
At close · Aug 21
Market Cap
$53.37M
Shares
5.78M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-03 | 2026-02 | $9,500,000 | — | — | 10-Q , filed 2026-05-12 |
Key facts
CIK
1840233
CUSIP
98422T209
13F (30d)
26 filings
26 filers
Visit website
Investor relations